Periorbital necrotizing fasciitis: the Manchester experience

BMC Ophthalmology

Table 1 Patients’ demographics, risk factors, wound, blood culture and tissue biopsy results, Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score and antibiotics therapy

Patient	Age	Gender	Risk Factors	Wound Swab Results	Blood Culture results	Tissue Biopsy Results	Antibiotics/anti-viral therapy at presentation
1	59	M	PR3 ANCA positive vasculitis, Type 2 DM	NG	Gram-positive cocci. NG	NF^a	Co-amoxiclav, metronidazole
2	63	F	Trauma	GAS	NG	NF^a, GAS	Ceftriaxone, clindamycin
3	42	M	Nil	GAS	NG	NF^a, GAS	Ceftriaxone, clindamycin
4	75	F	Right Herpes Zoster Ophthalmicus	GAS	NG	NF^a, GAS	Ceftriaxone, clindamycin, gentamicin, aciclovir
5	66	M	Nil	SA	NA	NF^a, GAS, SA	Ceftriaxone, clindamycin, metronidazole

DM Diabetes Mellitus, NG No growth, NA Not available, GAS Group A Streptococcus, SA Staphylococcus aureus
^aMorphological appearances on histology consistent with necrotising fasciitis (NF)

ISSN: 1471-2415